Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29280900

COc1ncccc1C(=O)NCC1CCN(CC(=O)c2ccc(Cl)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.42
F10 P00742 5/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
HTR4 Q13639 1/20 0.41
CACNA1I Q9P0X4 3/20 0.41
KCNH2 Q12809 1/20 0.41
CCR2 P41597 1/20 0.40
CHRM4 P08173 1/20 0.40
GPR6 P46095 1/20 0.40
SSTR1 P30872 1/20 0.40
SSTR4 P31391 1/20 0.40
IDO1 P14902 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL29280947 0.93 F10 (0.45) GSK3BF10DRD2DRD4
Trifluoroacetic Acid SCHEMBL29280931 0.93 GSK3B (0.42) GSK3BF10DRD2DRD4CACNA1I
Trifluoroacetic Acid SCHEMBL29280892 0.93 KDM4E (0.43) GSK3BDRD2DRD4HTR4KCNH2
Trifluoroacetic Acid SCHEMBL29280873 0.90 GPR6 (0.46) F10GPR6
SCHEMBL30839993 0.88 DRD2 (0.48) GSK3BDRD2DRD4GPR6
SCHEMBL29280895 0.86 PDE6D (0.45) GSK3BF10DRD2DRD4HTR4
SCHEMBL30843801 0.86 PDE6D (0.45) GSK3BF10DRD2DRD4HTR4
Trifluoroacetic Acid SCHEMBL29280904 0.85 GSK3B (0.45) GSK3BDRD2DRD4HTR4KCNH2
Trifluoroacetic Acid SCHEMBL29280926 0.81 KDM4E (0.45) GSK3BHTR4CACNA1IKCNH2CHRM4
SCHEMBL29280908 0.81 HTR7 (0.47) GSK3BDRD2DRD4HTR4CACNA1I

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820199-A Amide compound and application thereof in preparation of Sigma2 and 5HT2A inhibitors 瀚远医药有限公司 2024-04-05 CN disclosed